B. Sönmez UYDES DOGAN

Prof. Dr. B. Sönmez UYDES DOGAN

Department of Pharmacology, Istanbul University, Faculty of Pharmacy, Istanbul, Turkey (Türkiye), Istanbul, İstanbul, Turkey (Türkiye)
orcid
Istanbul University, Fac. of Pharmacy, Dept. of Pharmacology

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2022 in Journal of Asthma
Verified
Journal Article
Closed access
BGBilun Gemicioglu
Bilun Gemicioglu
NGNejdiye Gungordu
Nejdiye Gungordu
GCGünay Can
Günay Can
FYF. Ilkay Alp Yıldırım
F. Ilkay Alp Yıldırım
B. Sönmez UYDES DOGANB. Sönmez UYDES DOGAN
B. Sönmez UYDES DOGAN
The use of inhaler device (UID) and the satisfaction and adherence of patients to treatment were evaluated by Istanbul city community pharmacists to obtain real-life data from patients with asthma ...

1 January 2025 in PPAR Research
Verified
Journal Article
Open access
ECErkan Civelek
Erkan Civelek
EKEcem Fatma Karaman
Ecem Fatma Karaman
SÖSibel Özden
Sibel Özden
B. Sönmez UYDES DOGANB. Sönmez UYDES DOGAN
B. Sönmez UYDES DOGAN
DDDeniz Kaleli Durman
Deniz Kaleli Durman
Perivascular adipose tissue (PVAT) plays a crucial role in vascular homeostasis. Recent studies in adipose tissue demonstrated that endoplasmic reticulum (ER) stress and autophagy are activated in Type 2 diabetes mellitus (T2DM), while the precise role of ER stress and autophagy in PVAT is unclear. We aimed to investigate the possible influence of pioglitazone on ER stress and autophagy response in PVAT of T2DM rats. T2DM was induced by high‐fat diet/low‐dose streptozotocin (HFD/STZ) in male Wistar rats (8–10 weeks), and pioglitazone (20 mg/kg/p.o.) was administered for 6 weeks. Changes in biochemical parameters (nonfasting glucose, total cholesterol, and triglyceride) were verified in blood samples. ER stress–related ( ATF4 , CHOP , and GRP78 ) and autophagy‐related ( MAP1LC3B /LC3‐II, BECN-1/ Beclin, and SQSTM1 /p62) gene expression levels in thoracic PVAT were measured by RT‐PCR. Pioglitazone treatment reversed the increased nonfasting glucose and triglyceride levels in T2DM. ER stress and autophagy responses were significantly increased in PVAT of T2DM rats. Pioglitazone increased ER stress–related GRP78 gene expression while decreasing autophagy‐related MAP1LC3B and BECN-1 gene expression levels in T2DM. Interestingly, SQSTM1 gene expression levels were increased by pioglitazone in the control and T2DM groups. The current study provides original findings regarding the effects of pioglitazone on ER stress and autophagy response in PVAT of HFD/STZ‐induced T2DM rats. Pioglitazone treatment in T2DM increased GRP78 and SQSTM1 gene expressions, which both play a crucial role in adipocyte differentiation and adipogenesis, besides ER stress and autophagy. Further studies clarifying the adipogenic effect of pioglitazone on PVAT are needed for a better understanding of its effect on the vascular system.

1 January 2025 in Canadian Journal of Physiology and Pharmacology
Verified
Journal Article
Closed access
ECErkan Civelek
Erkan Civelek
EKEcem Fatma Karaman
Ecem Fatma Karaman
SÖSibel Özden
Sibel Özden
NBNur Büyükpınarbaşılı
Nur Büyükpınarbaşılı
B. Sönmez UYDES DOGANB. Sönmez UYDES DOGAN
B. Sönmez UYDES DOGAN
DDDeniz Kaleli Durman
Deniz Kaleli Durman
Perivascular adipose tissue (PVAT) plays an important role in many physiological and pathological processes, such as regulation of vascular tone. The aim of this study is to evaluate the effects of pioglitazone on functional, structural, and biochemical properties of PVAT in an experimental model of type-2 diabetes (T2DM). T2DM was induced by high-fat-diet/low-dose-streptozotocin in rats, and pioglitazone (20 mg/kg/p.o.) was administered for 6 weeks. Changes in biochemical parameters, PVAT-mass, vascular-reactivity in thoracic-aorta, as well as PVAT adipocytokine and PPARG-expression levels, and histopathology were evaluated. Pioglitazone administration improved blood glucose and lipid profiles in T2DM. Pioglitazone did not change the anticontractile effect of PVAT on aortic contractile reactivity and besides, had no influence on endothelium-dependent and -independent relaxation responses. Pioglitazone administration increased PVAT-mass and tumor necrotizing factor-α levels, while adiponectin, leptin, and interleukin-6 levels were unchanged. Also, a prominent increase was observed in PPARG-expression in T2DM-Pio group. Moreover, pioglitazone decreased liver steatosis, aortic wall thickening, and myocardial damage, whereas increased adipocyte size and adiposity in PVAT. Overall, pioglitazone treatment changed the mass and in part the inflammatory profile of PVAT but did not modify vasoreactivity in T2DM. This study provides novel findings in relationship with the adipogenic effect of pioglitazone and PVAT function.

18 June 2026 in European Journal of Clinical Pharmacology
Verified
Journal Article
Open access
PDF file
IKİlKer Kurt
İlKer Kurt
EKEsen Gül Koçak
Esen Gül Koçak
MŞMeliha Şen
Meliha Şen
BMBilgul Mete
Bilgul Mete
GAGökhan Aygün
Gökhan Aygün
ZKZeliha Pala Kara
Zeliha Pala Kara
Purpose: Vancomycin therapeutic drug monitoring is essential for optimizing efficacy and reducing the risk of vancomycin-associated acute kidney injury (VA-AKI). Although recent guidelines recommend the ratio of area under the curve over 24 h to minimum inhibitory concentration (AUC 24 /MIC)–based monitoring over trough concentration-based monitoring, differences between AUC 24 /MIC estimation methods (e.g., pharmacokinetic equations and Bayesian approaches) may influence therapeutic classification in clinical practice. In addition, pharmacogenetic factors contributing to interindividual variability in vancomycin exposure remain incompletely characterized. Methods: This prospective, single-center cohort study included adult patients who received intravenous vancomycin for at least 72 h between June 2024 and April 2025. Vancomycin trough and peak plasma concentrations were measured using an enzyme-linked immunosorbent assay. AUC 24 /MIC values were calculated using pharmacokinetic equation and Bayesian method. Agreement in therapeutic classification between trough concentration–based and AUC 24 /MIC-based monitoring was assessed. Associations between the rs2789047 genetic variant and relevant parameters were also evaluated. Results: Thirty-six patients were included, of whom 38.9% developed VA-AKI. Despite strong correlations between trough concentration and AUC 24 /MIC values ( r = 0.84–0.87), substantial discordance in therapeutic classification was observed, with agreement rates of 63.9% for pharmacokinetic equation-based and 66.7% for Bayesian-based compared with trough concentration-based monitoring. In contrast, pharmacokinetic equation-based and Bayesian-based methods demonstrated strong concordance (86.1%). Higher trough concentrations and AUC 24 /MIC values were significantly associated with VA-AKI ( p < 0.001). Carriers of rs2789047 A-allele exhibited higher trough concentrations and reduced elimination rates. Conclusion: Trough concentration-based monitoring frequently misclassified vancomycin exposure compared with AUC 24 /MIC–based approaches. Pharmacogenetic variability may further influence vancomycin exposure.

29 December 2024 in Clinical and Experimental Health Sciences
Verified
Journal Article
Closed access
DDDeniz Kaleli Durman
Deniz Kaleli Durman
RARuveyda Aktaş
Ruveyda Aktaş
MAMeryem Aras
Meryem Aras
B. Sönmez UYDES DOGANB. Sönmez UYDES DOGAN
B. Sönmez UYDES DOGAN
Objective: Rosuvastatin displays favorable pleiotropic effects on vascular system to reduce the risk of cardiovascular events besides providing an intensive reduction in LDL-C levels. The role of perivascular adipose tissue (PVAT) in modulating the vasorelaxant effect of rosuvastatin is not evaluated so far. The present study aimed to investigate the vascular relaxant effect of rosuvastatin in rat aortic rings with intact PVAT, as well as to evaluate the possible mechanisms underlying this effect in relation to nitric oxide (NO) and prostaglandin pathways. Methods: Thoracic aorta rings with intact PVAT, isolated from male Wistar rats (n=5), were mounted on an isolated organ bath system. Endothelium-dependent responses to acetylcholine (Ach,10-6-10-4M) were obtained in aortic rings precontracted submaximally with phenylephrine (Phe,10-6-3x105M). The concentration-dependent relaxant effect of rosuvastatin (10-7-10-4M) was examined in the absence and presence of NO inhibitor, L-NOARG (10-4M, 30min.) and cyclooxygenase inhibitor, indomethacin (10-5M, 30min.). Vascular relaxation capacity of aortic rings was checked by the nitrovasodilator, sodium nitroprusside (SNP,10-6 M) at the end of the experiments. Results: Rosuvastatin (10-7-10-4M) produced concentration-dependent relaxations in Phe-precontracted rat aortic rings with intact PVAT. Pretreatment with L-NOARG significantly attenuated the relaxant responses to rosuvastatin in isolated rat aortic rings with intact PVAT. However, pretreatment with indomethacin did not modify the relaxations to rosuvastatin. In the aortic rings, maximal relaxation responses to Ach and SNP were determined to be 75.87±2.68% and 102.54±2.92%, respectively. Conclusions: This study will provide a basis for investigating the interaction between PVAT and statins in vascular homeostasis.

19 July 2025 in Life
Verified
Journal Article
Open access
PDF file
DDDeniz Kaleli Durman
Deniz Kaleli Durman
NDNurdan Dağtekin
Nurdan Dağtekin
ECErkan Civelek
Erkan Civelek
TITaner İyigün
Taner İyigün
ÖTÖnder Teskin
Önder Teskin
B. Sönmez UYDES DOGANB. Sönmez UYDES DOGAN
B. Sönmez UYDES DOGAN
S-nitrosoglutathione (GSNO), a promising S-nitrosothiol, has been recognized for its ability to modulate vascular tone through its vasodilatory, antiplatelet, and antiproliferative effects. However, data on its vasodilatory effects in human vessels remain limited, and its mechanisms of action have yet to be fully elucidated. In this study, we aimed to investigate the vasorelaxant effect of GSNO and its underlying mechanisms, with particular focus on the soluble guanylate cyclase (sGC)/nitric oxide (NO) pathway and potassium channels in isolated human saphenous veins (SVs) obtained from patients undergoing coronary artery bypass grafting (CABG). GSNO (10−8–10−4 M) produced concentration-dependent relaxations in SV rings precontracted with phenylephrine. These relaxations were unaffected by NO synthase inhibition with L-NAME (10−4 M, 30 min) or NO scavenging with PTIO (10−4 M, 30 min), but were significantly reduced by the sGC inhibitor, ODQ (10−5 M, 30 min). Inhibition of ATP-sensitive (glibenclamid; 10−5 M, 30 min.), high-conductance Ca2+-activated (charybdotoxin; 10−7 M, 30 min), small-conductance Ca2+-activated (apamin; 10−6 M, 30 min), or voltage-dependent (4-aminopyridine; 10−3 M, 30 min) potassium channels did not alter the maximum relaxant responses to GSNO. Furthermore, pretreatment with GSNO (10−4 M, 30 min) significantly attenuated both the contractile response and sensitivity to phenylephrine. Collectively, these findings demonstrate that GSNO exerts acute vasorelaxant and modulatory effects in human SV primarily via cGMP-dependent mechanisms, highlighting its potential as a local therapeutic agent for preventing graft spasm in CABG.